Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Hui Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9326-6649; OpenAlex author ID A5100334151. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

  1. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Last author DOI 10.3892/ijo.2020.4956↗
  2. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy. Last author DOI 10.1159/000490027↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongfei Tong · 1 shared paper, 2020 · strength 0.11
  2. Zhong Hong · 1 shared paper, 2020 · strength 0.11
  3. Zhaohong Wang · 1 shared paper, 2020 · strength 0.11
  4. Muhammad Babar Jamshed · 1 shared paper, 2020 · strength 0.11
  5. Qiyu Zhang · 1 shared paper, 2020 · strength 0.11
  6. Limin Huang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.